BioCentury
ARTICLE | Financial News

Syndax amends IPO

June 9, 2014 7:00 AM UTC

Syndax Pharmaceuticals Inc., Waltham, Mass. Business: Cancer Date announced: 6/5/14 Type: IPO To be raised: Up to $64.5 million Shares: 4.3 million Price: $13-$15 Underwriters: Deutsche Bank; Jefferie...